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Abstract
The 24-hour time-line for symptoms in the current definition of stroke is 
arbitrary. Moreover, this definition does not include silent stroke, encourage 
acute stroke therapy and consider dramatic recovery after successful therapy. 
Silent stroke, which is five times more common than symptomatic stroke, is a 
risk factor for future stroke and is associated with adverse neurological and 
cognitive functions. Whilst pathological confirmation remains the gold standard 
in defining stroke and its underlying etiology, widely available neuroimaging has 
greatly obviated the need for post-mortem examination. Modern multimodal 
neuroimaging permits confirmation of infarction and/or hemorrhage in the 
central nervous system, reveals the location and size of the vascular lesion, 
excludes the stroke mimics and evaluates the relevant cerebrovascular 
anatomy. Nevertheless, neuroimaging may be limited to an unenhanced 
computed tomography of the brain. Furthermore, stroke symptoms may resolve 
either spontaneously or upon successful thrombolysis despite development of 
new infarction or hemorrhage. It was timely for the American Heart Association 
and American Stroke Association to publish an updated definition of stroke in 
July 2013. This updated definition of stroke incorporates both clinical and tissue 
criteria and comprises of ten possible definitions of stroke. The latter include 
silent infarction and silent hemorrhage. One problem of the updated definition 
is major overlaps among the definitions. Another problem is the non-systematic 
nature of the definitions. This editorial proposes a comprehensive and systematic 
approach to the definition of stroke by incorporating the following factors: level of 
certainty, presence and nature of symptoms, duration of symptoms, pathological 
types, and underlying etiologies.
Keywords: Cerebral Hemorrhage; Cerebral Infarction; Silent Stroke; 
Stroke; Stroke Definition; Transient Ischemic Attack
Review Article
A Systematic Approach to the Definition of Stroke
Cheung RTF*
Division of Neurology, Department of Medicine, Li Ka 
Shing Faculty of Medicine, The University of Hong Kong, 
Pokfulam, Hong Kong
*Corresponding author: Cheung RTF, Division 
of Neurology, Department of Medicine, Queen Mary 
Hospital, 102 Pokfulam Road, Hong Kong, Tel: 852-2255-
4049; Fax: 852-2818-6474; Email: rtcheung@hkucc.hku.
hk
Received: August 18, 2014; Accepted: September 26, 
2014; Published: September 29, 2014
Austin
Publishing Group
A
Abbreviations
AHA: American Heart Association; ASA: American Stroke 
Association; CNS: Central Nervous System; CT: Computed 
Tomography; CVT: Cerebral Venous Thrombosis; ICH: Intracerebral 
Hemorrhage; MRI: Magnetic Resonance Imaging; SAH: Subarachnoid 
Hemorrhage; TIA: Transient Ischemic Attack.
Current Definition of Stroke
Stroke is a non-traumatic, focal vascular-induced injury of the 
central nervous system (CNS) and typically results in permanent 
damage in the form of cerebral infarction, intracerebral hemorrhage 
(ICH) and/or subarachnoid hemorrhage (SAH). Stroke is a leading 
cause of death and disability worldwide. “Apoplexy” is derived from 
“apoplexia”, which is a Greek word meaning “a striking away”. 
Hippocrates of Cos used “apoplexy” to describe very acute, often 
fatal, non-traumatic brain injuries at 400 BC [1]. In 1689, William 
Cole first used “stroke” to denote “apoplexy” [2]. “Transient ischemic 
attack” (TIA) was introduced in 1950s to describe a temporary 
episode of vascular-related brain dysfunction not qualifying as 
stroke. The current definition of stroke was introduced by the World 
Health Organization in 1970 as “rapidly developing clinical signs of 
focal or global disturbance of cerebral function, lasting more than 
24 hours or leading to death, with no apparent cause other than that 
of vascular origin” [3]. TIA was defined in 1975 as “temporary and 
focal dysfunction of vascular origin of a variable duration up to 24 
hours” [4]. Conceptually stroke will lead to irreversible CNS damage 
with persistent symptoms unless promptly and successfully treated, 
whereas TIA should not produce either CNS damage or persistent 
symptoms. Indeed the 24-hour cut-off line for symptoms was 
arbitrarily chosen to demarcate stroke from TIA. Advances in basic 
neuroscience, neuropathology and neuroimaging in the past four 
decades have casted serious doubt about the validity of the current 
definitions of stroke and TIA.
Insofar stroke is a manifestation of non-traumatic vascular disease 
of the CNS, the ischemic or hemorrhagic tissue injury can be located 
in the brain, spinal cord and/or retina. Functional consequences, if 
any, are not limited to cerebral symptoms; symptoms of stroke may 
be due to involvement of the spinal cord or retina, e.g. central cord 
syndrome, Brown Séquard syndrome, complete cord syndrome, 
monocular blindness, scotoma. Symptoms mimicking stroke can be 
due to traumatic vascular disease and non-vascular diseases. Thus, 
stroke mimics must be considered and excluded by appropriate 
investigations.
Unless the brainstem or bilateral cerebral hemispheres is/are 
severely affected by the stroke process or stroke is complicated by 
markedly raised intracranial pressure, symptoms of stroke should 
be focal rather than global in nature. Thus, symptoms and signs of 
stroke should be consistent with the location and nature of vascular-
induced CNS injury. The vascular process of occlusion or rupture 
may involve the artery, capillary, vein and venous sinus, including 
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atherothrombosis, cardioembolic arterial occlusion, artery-to-
artery embolism, small vessel disease, aneurysm, arteriovenous 
malformation, cortical vein thrombosis, venous sinus thrombosis, 
and dural arteriovenous fistula. Underlying disease process and risk 
factors should be evaluated to help select our preventive measures.
The 24-hour criterion for symptoms of stroke is misleading 
because modern neuroimaging, especially diffusion weighted imaging 
of magnetic resonance imaging (MRI), reveals that CNS infarction 
can develop much sooner. On the other hand, CNS tissue can survive 
without infarction for up to days of moderate ischemia. Despite 
spontaneous resolution of symptoms of stroke within 24 hours of 
onset, small new cerebral infarction, intracerebral hemorrhage or 
subarachnoid hemorrhage can be documented on neuroimaging. 
Indeed neuroimaging studies, especially using MRI, on stroke 
patients and people without a prior history of stroke have revealed 
silent cerebral infarction and/or silent hemorrhage, which are five 
times more common than stroke with symptoms [5]. Moreover, 
successful recanalization of the arterial occlusion plus timely 
revascularization of the ischemic CNS tissue can achieve complete 
resolution of symptoms within 24 hours with or without new 
infarction on neuroimaging [6]. Thus, duration of stroke symptoms 
should be a secondary consideration when tissue information is 
absent or insufficient.
Updated Definition of Stroke
It was timely for the American Heart Association (AHA) 
and American Stroke Association (ASA) to publish an updated 
definition of stroke in July 2013. This updated definition of stroke 
comprises of ten possible scenarios: CNS infarction, ischemic stroke, 
silent CNS infarction, ICH, stroke caused by ICH, silent cerebral 
hemorrhage, SAH, stroke caused by SAH, stroke caused by cerebral 
venous thrombosis (CVT), and not otherwise specified stroke [7]. As 
pathological confirmation of stroke is generally lacking and computed 
tomography (CT) is widely available, AHA/ASA emphasized that 
stroke is a clinical and radiological diagnosis. Symptoms and signs 
should be interpreted according to our knowledge of neuroanatomy, 
vascular anatomy and vascular pathology, i.e. the lesion location, 
affected blood vessel and disease mechanism. The latter is related to 
general systemic diseases and family history of illnesses, and non-
vascular processes causing stroke mimics must be considered unlikely.
Modern multimodal MRI or CT neuroimaging permits confirmation 
of infarction and hemorrhage in the CNS, reveals the location and 
size of the vascular lesion, excludes the stroke mimics and evaluates 
the relevant cerebrovascular anatomy [8]. Nevertheless, multimodal 
neuroimaging is time consuming and therefore counterproductive 
in minimizing any delay in revascularization treatment for acute 
ischemic stroke.
CNS infarction refers to ischemic cell death in the brain, spinal 
cord or retina in a defined vascular territory based on objective, i.e., 
pathological, imaging or other, evidence or pure clinical evidence, 
i.e., with either symptoms of neurological dysfunction lasting ≥24 
hours or a rapidly fatal outcome. Other etiologies should be excluded. 
Explicit inclusion of spinal cord and retina is an advantage of this 
definition. Another advantage is the use of either objective or pure 
clinical evidence of ischemic damage. This definition also includes 
type I and II hemorrhagic infarctions. Hemorrhagic infarctions are 
hemorrhages without mass effect within the infarctions; type I is 
characterized by discrete petechiae and type II by confluent petechiae.
Ischemic stroke refers to an episode of neurological dysfunction, 
i.e., clinical evidence, due to focal cerebral, spinal or retinal infarction; 
infarction is based on objective evidence. In other words, stroke 
is characterized by symptoms, and the 24-hour time line is not 
mandatory if there is objective evidence of CNS infarction. On the 
other hand, silent ischemic stroke is not considered by this definition.
Silent CNS infarction refers to objective evidence of CNS 
infarction without any clinical evidence. In other words, there are no 
relevant symptoms of stroke.
ICH refers to a focal collection of blood within the brain 
parenchyma or ventricles not due to trauma. Unlike other definitions 
of stroke, this does not include non-traumatic hemorrhage within 
the subarachnoid space, spinal cord and retina. This definition also 
includes type I and II parenchymal hemorrhages after cerebral 
infarction. Unlike type I and II hemorrhagic infarctions, mass effect 
is present; type I is limited to ≤30% of the infarction and type II >30%.
Stroke caused by ICH refers to an episode of neurological 
dysfunction, i.e., clinical evidence, due to ICH. In other words, this 
is symptomatic ICH.
Silent cerebral hemorrhage refers to an asymptomatic focal 
collection of old blood within the brain parenchyma, ventricles 
or subarachnoid space not due to trauma. In other words, this is 
asymptomatic old ICH or SAH.
SAH refers to bleeding into the subarachnoid space of the brain 
or spinal cord. As trauma is not specifically excluded, this definition 
may include both traumatic and non-traumatic SAH.
Stroke caused by SAH refers to an episode of neurological 
dysfunction, i.e., clinical evidence, and/or headache due to non-
traumatic SAH. In other words, this is symptomatic non-traumatic 
SAH.
Stroke caused by CVT refers to CNS infarction or hemorrhage 
due to thrombosis of a cerebral venous structure. Neurological 
dysfunctions, i.e., clinical evidence, caused by reversible edema alone 
are insufficient.
Not otherwise specified stroke refers to pure neurological 
dysfunction, i.e., clinical evidence, with insufficient information 
to allow classification into one of the above AHA/ASA definitions 
of stroke. Presumably there is no pathological, imaging or other 
objective evidence of stroke.
As summarized above, the AHA/ASA definition of stroke 
addresses many deficiencies of the current definition and includes 
silent infarction and hemorrhage. Nevertheless, the updated definition 
of stroke does not address all the limitations of the current definition 
[7]. The 24-hour arbitrary time-line is still required as part of the 
clinical evidence for the diagnosis of stroke unless there is objective, 
i.e., pathological, imaging or other, evidence. Despite the slogan of 
‘time is brain’ in stroke management, the AHA/ASA definition does 
not encourage acute stroke therapy or consider dramatic recovery 
after successful therapy. This is also the case for stroke caused by 
CVT. Presence of neurological dysfunctions attributable to CVT 
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should justify commencement of anticoagulation, treatment of the 
underlying cause and other supportive treatment [9]. If prompt and 
appropriate treatment of CVT prevents the development of CNS 
infarction and hemorrhage, the updated definition of stroke would 
not regard the event as stroke caused by CVT. According to the AHA/
ASA definition, this event is either a not otherwise specified stroke or 
not a stroke at all [7].
The updated definition of stroke is not as clear as the current 
definition on some aspects [7]. One problem of the updated 
definition is major overlaps among the ten scenarios. The definition 
of CNS infarction may include silent CNS infarction, but the latter 
is separately defined. At the same time, there is a separate definition 
of ischemic stroke as symptomatic CNS infarction. The definition of 
ICH includes type I and II parenchymal hemorrhages after cerebral 
infarction but excludes type I and II hemorrhagic infarctions. In the 
absence of a prior documentation of cerebral infarction, however, it 
is impossible to distinguish between parenchymal hemorrhage and 
ICH. Moreover, this definition of ICH may include silent ICH because 
clinical symptom is not specified; yet silent cerebral hemorrhage is 
separately defined. At the same time, there is a separate definition of 
stroke caused by ICH as symptomatic ICH. Similarly the definition 
of SAH does not specify any clinical symptom, but silent SAH is 
included in the definition of silent cerebral hemorrhage. In addition, 
there is a separate definition for stroke caused by SAH.
In general, the AHA/ASA definition of stroke uses the term 
‘stroke’ to emphasize clinical evidence and the terms ‘infarction’ and 
‘hemorrhage’ to emphasize objective evidence from pathology and/or 
radiology [7]. Yet the chosen terminology is rather non-systematic, 
vague and non-equivalent. The definition of not otherwise specified 
stroke is an example. In the absence of pathological or imaging 
information, it is not possible to distinguish between ischemic and 
hemorrhagic strokes and to exclude stroke mimics. Another example 
is the definition of stroke caused by CVT. This definition does not 
include silent CVT and symptomatic CVT without infarction or 
hemorrhage. In addition, it is not clear how infarction or hemorrhage 
in the spinal cord, which is part of CNS, can be caused by thrombosis 
of a cerebral venous structure in stroke caused by CVT.
A Systematic Approach to the Definition of 
Stroke
As pointed out by AHA/ASA, the purpose of an updated 
definition of stroke is for diagnosis in clinical practice, in clinical 
research and in assessments of the public health [7]. This editorial 
proposes a comprehensive and systematic approach by incorporating 
the following factors: level of certainty, presence and nature of 
symptoms, duration of symptoms, pathological types, and underlying 
etiologies. These principles are used in the diagnostic definitions of 
many neurological conditions, e.g. migraine, tension-type headache, 
Alzheimer’s disease, vascular dementia, multiple sclerosis, and 
Creutzfeldt-Jakob disease [10-14].
As a non-traumatic focal vascular-induced injury of the CNS with 
a potential consequence of cerebral, spinal or retinal infarction and/or 
hemorrhage, the definition of stroke should include both clinical and 
tissue criteria [7]. Symptoms and signs, if any, should be compatible 
with the location and nature of tissue damage. Duration of symptoms, 
such as 24 hours or longer, is irrelevant when tissue damage is present 
or upon successful implementation of revascularization in acute 
ischemic stroke. Spontaneous resolution of stroke symptoms within 
24 hours justifies the terminology of reversible stroke instead of 
TIA. Appropriate investigations should be performed to confirm the 
location and nature of tissue damage and vascular lesion, exclude the 
stroke mimics and evaluate the underlying etiology. In the absence 
of tissue confirmation, such uncertainty warrants the terminology 
of possible stroke. CNS venous thrombosis is a recognized cause of 
infarction, hemorrhage or both. Edema may not be distinguishable 
from infarction especially upon prompt initiation of anticoagulation.
Thus the following scenarios are included in the proposed definition 
of stroke.
Possible stroke refers to a clinical syndrome of neurological 
dysfunction due to presumed non-traumatic vascular cause of 
focal cerebral, spinal or retinal infarction or hemorrhage. Relevant 
symptoms should be 24 hours or longer unless the outcome is 
rapidly fatal. Confirmation of location and nature of tissue damage 
is unavailable. Under the circumstance, stroke mimics cannot be 
reliably excluded; the underlying etiology is either uncertain or 
merely assumed from the known history of vascular risk factors.
Possible reversible stroke refers to a clinical syndrome of 
neurological dysfunction due to presumed non-traumatic vascular 
cause of focal cerebral, spinal or retinal infarction or hemorrhage. 
Relevant symptoms should spontaneously and completely resolve 
within 24 hours. Confirmation of location and nature of tissue 
damage is unavailable. This is equivalent to TIA with inadequate work 
up but a small hemorrhage with transient symptoms is a possibility.
Under the circumstance, stroke mimics cannot be reliably excluded; 
the underlying etiology is either uncertain or merely assumed from 
the known history of vascular risk factors.
Ischemic stroke refers to a clinical syndrome of neurological 
dysfunction due to presumed non-traumatic vascular cause of focal 
cerebral, spinal or retinal infarction. Relevant symptoms should be 
24 hours or longer unless the outcome is rapidly fatal or the fast 
resolution of symptoms is attributed to a dramatic response to acute 
revascularization. CNS hemorrhage is excluded. Confirmation of 
location of CNS infarction may be available. Acute CNS infarction 
may not be discernable when neuroimaging is limited to an urgent 
unenhanced CT brain. In addition, new CNS infarction may be absent 
because of an excellent response to acute revascularization. Under 
the circumstance, stroke mimics can be reliably excluded. Depending 
on thoroughness of investigations, the underlying etiology may be 
elucidated or assumed from the known history of vascular risk factors.
Reversible ischemic stroke refers to a clinical syndrome of 
neurological dysfunction due to presumed non-traumatic vascular 
cause of focal cerebral, spinal or retinal infarction. Relevant symptoms 
should spontaneously and completely resolve within 24 hours. CNS 
hemorrhage is excluded. Confirmation of location of CNS infarction 
may be available but CNS infarction may not be discernable when 
neuroimaging is limited to an urgent unenhanced CT brain. This is 
equivalent to TIA with adequate work up. Under the circumstance, 
stroke mimics can be reliably excluded. Depending on thoroughness 
of investigations, the underlying etiology may be elucidated or 
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assumed from the known history of vascular risk factors.
Silent ischemic stroke refers to detection of focal cerebral, spinal 
or retinal infarction of presumed non-traumatic vascular cause. 
Relevant symptoms cannot be recalled or documented. Depending 
on thoroughness of investigations, the underlying etiology may 
be elucidated or assumed from the known history of vascular 
risk factors. Co-existing silent CNS hemorrhage is possible. It is 
envisaged that silent spinal infarction may not be distinguishable 
from demyelinating or cystic lesions on pure neuroimaging ground.
Hemorrhagic stroke refers to a clinical syndrome of neurological 
dysfunction due to presumed non-traumatic vascular cause of focal 
cerebral, spinal or retinal hemorrhage. Relevant symptoms should be 
24 hours or longer unless the outcome is rapidly fatal. Confirmation 
of location of CNS hemorrhage, i.e., intracerebral, intraventricular, 
subarachnoid, intraspinal or retinal, is available. Under the 
circumstance, stroke mimics can be reliably excluded. Depending 
on thoroughness of investigations, the underlying etiology may 
be elucidated or assumed from the known history of vascular risk 
factors. Hemorrhagic stroke can be a complication of ischemic stroke 
especially following acute revascularization.
Reversible hemorrhagic stroke refers to a clinical syndrome 
of neurological dysfunction due to presumed non-traumatic 
vascular cause of focal cerebral, spinal or retinal hemorrhage. 
Relevant symptoms should spontaneously and completely resolve 
within 24 hours. Confirmation of location of CNS hemorrhage, 
i.e., intracerebral, intraventricular, subarachnoid, intraspinal or 
retinal, is available. Under the circumstance, stroke mimics can be 
reliably excluded. Depending on thoroughness of investigations, the 
underlying etiology may be elucidated or assumed from the known 
history of vascular risk factors. Reversible hemorrhagic stroke can 
be a complication of ischemic stroke especially following acute 
revascularization.
Silent hemorrhagic stroke refers to detection of old focal cerebral 
or spinal hemorrhage of presumed non-traumatic vascular cause on 
T2*-weighted or gradient echo MRI [8]. Relevant symptoms cannot 
be recalled or documented. Confirmation of location of previous 
CNS hemorrhage, i.e. intracerebral, periventricular or intraspinal is 
available. Co-existing silent ischemic stroke is possible. Depending 
on thoroughness of investigations, the underlying etiology may be 
elucidated or assumed from the known history of vascular risk factors.
Concluding Remarks
Stroke is a clinical and tissue diagnosis of great global impact and 
implications. Clinical diagnosis of stroke without further information 
or confirmation of non-traumatic vascular damage should be allowed. 
Complete resolution of symptoms can occur spontaneously or in 
response to successful revascularization. In case of spontaneous and 
complete recovery, it is preferable to call it a reversible stroke rather 
than a TIA. Tissue definition of stroke is mainly based on neuroimaging 
data because pathological confirmation is generally lacking. Non-
traumatic vascular tissue damage is sufficient but not necessary for 
the diagnosis of stroke. Unlike acute myocardial ischemia, sensitive 
and specific laboratory or electrical diagnostic tests for stroke are not 
available. Whilst advanced multimodal neuroimaging can provide 
comprehensive and diagnostic information for stroke, this is time 
consuming, expensive and unavailable in the developing world. A 
comprehensive and systematic approach to the definition of stroke 
is warranted. The proposed definition of stroke would consider the 
level of certainty, presence and nature of symptoms, duration of 
symptoms, pathological types, and underlying etiologies. Adoption 
of the proposed definition will facilitate diagnosis of stroke in clinical 
practice, in clinical research and in assessments of the public health. 
When stroke is suspected because of relevant symptoms, prompt 
and timely investigations and treatment are indicated. Detection of 
silent stroke would justify assessment and management of vascular 
risk factors for stroke prevention. Clinical trials and stroke databases 
will drive our future advances in epidemiology, pathophysiology, 
acute intervention and prevention of stroke. Nevertheless, these 
studies should adopt a standardized definition of stroke. Public health 
assessment is the systematic collection, analysis and interpretation of 
health-related data needed for the planning, implementation, and 
evaluation of public health practice. A revised definition of stroke 
wills inevitably change the incidence, prevalence and mortality of 
stroke. Allowance of different levels of certainty and variations in 
thoroughness of investigations would bring a global perspective to 
public health surveillance of stroke.
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